Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -334,795 (Position Closed) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 6,811,631 6.400% | -756,849 (-10.00%) | Filing History |
| 2024-11-14 4:29 pm Sale | 2024-09-30 | 13G | AN2 Therapeutics, Inc. ANTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,563,963 (Position Closed) | Filing History |
| 2024-11-14 4:29 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | BIOTECHNOLOGY VALUE FUND L P | 1,047,123 9.990% | 700,101 (+201.74%) | Filing History |
| 2024-11-14 4:28 pm Purchase | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 6,230,845 9.990% | 1,779,960 (+39.99%) | Filing History |
| 2024-11-14 4:27 pm Sale | 2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX | BIOTECHNOLOGY VALUE FUND L P | 2,970,427 4.900% | -2,793,521 (-48.47%) | Filing History |
| 2024-11-14 4:27 pm Purchase | 2024-09-30 | 13G | Zymeworks Inc. ZYME | BIOTECHNOLOGY VALUE FUND L P | 4,607,935 6.500% | 4,607,935 (New Position) | Filing History |
| 2024-11-14 4:26 pm Purchase | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 8,089,795 9.990% | 1,386,906 (+20.69%) | Filing History |
| 2024-11-14 4:26 pm Sale | 2024-09-30 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -24,435,632 (Position Closed) | Filing History |
| 2024-11-14 4:24 pm Purchase | 2024-09-30 | 13G | Cullinan Therapeutics, Inc. CGEM | BIOTECHNOLOGY VALUE FUND L P | 5,796,433 9.990% | 1,403,112 (+31.94%) | Filing History |
| 2024-11-14 4:24 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -4,579,818 (Position Closed) | Filing History |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | IDEAYA Biosciences, Inc. IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,409,993 1.700% | -2,069,050 (-59.47%) | Filing History |
| 2024-11-14 4:22 pm Purchase | 2024-09-30 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 703,126 9.990% | 703,126 (New Position) | Filing History |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | Delcath Systems, Inc. DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,041,667 3.600% | -1,296,759 (-55.45%) | Filing History |
| 2024-11-14 4:20 pm Sale | 2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -8,774,570 (Position Closed) | Filing History |
| 2024-11-13 4:08 pm Purchase | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 7,382,642 14.200% | 3,375,229 (+84.22%) | Filing History |
| 2024-11-12 5:27 pm Sale | 2024-11-07 | 13G | Third Harmonic Bio, Inc. THRD | BIOTECHNOLOGY VALUE FUND L P | 2,372,933 5.300% | -1,993,000 (-45.65%) | Filing History |
| 2024-11-01 4:27 pm Purchase | 2024-10-25 | 13G | Septerna, Inc. SEPN | BIOTECHNOLOGY VALUE FUND L P | 2,452,024 5.500% | 2,452,024 (New Position) | Filing History |
| 2024-10-31 5:50 pm Unchanged | 2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 6,293,282 10.500% | 0 (Unchanged) | Filing History |
| 2024-10-31 5:49 pm Purchase | 2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 6,293,282 15.900% | 1,966,572 (+45.45%) | Filing History |